<DOC>
	<DOCNO>NCT02520960</DOCNO>
	<brief_summary>Prospective observational multicentric study evaluate efficacy consider unipolar signal modification radio frequency catheter ablation patient symptomatic paroxysmal atrial fibrillation France November 2013 January 2015 . All procedure conduct accord standard clinical care current guideline . Pulmonary vein isolation guide accord force ( least 10 gram ) application vector ( perpendicular wall ) develop atrial unipolar electrogram recording become complete positive signal . Patients discharge hospital free anti-arrhythmic drug . Recurrence arrhythmias 12 month ( primary outcome ) assess continuous 48-hour Holter 1 , 3 , 6 , 9 12 month post-catheter ablation .</brief_summary>
	<brief_title>Unipolar Atrial Electrogram Modification Combined Contact Force Sensing Technology Pulmonary Vein Isolation</brief_title>
	<detailed_description>Patients Setting : Consecutive patient refer participate institution , November 2013 January 2015 , catheter ablation symptomatic drug resistant paroxysmal atrial fibrillation ( AF ) enrol observational 12-follow study . Paroxysmal AF define episode AF terminate spontaneously less seven day . Eligibility criterion , well outcome measure detailed section . Radiofrequency catheter ablation AF : All procedure conduct accord standard clinical care North American European guideline . Of note , investigator assign specific intervention subject study , intervention ( trans-oesophageal echocardiography , pulmonary vein isolation ) recommend American Heart Association European Society Cardiology . AF catheter ablation conduct efficient vitamin K antagonist ( INR 2-3 ) general anesthesia without discontinuation anti-arrhythmic drug ( AAD ) . Trans-esophageal echocardiography perform patient within 48 hour procedure exclude intra-cardiac thrombus . Two long sheath ( Preface™ , Biosense Webster , Diamond Bar , CA SLO™ , Saint Jude Medical , Minnetonka , MN ) advance LA two trans-septal puncture . Intravenous heparin administer target activate clotting time beyond 320 second . Three catheter , insert right femoral vein , use map ablation : 6F non deflectable hexapolar 2.5-2.5-2.5-2.5-247.5 mm interspacing electrode catheter place high right atrium ( RA ) coronary sinus ( CS ) whenever possible ( Curve : A-Josephson type , Biosense Webster ) , proximal electrode place level inferior vena cava , 7F circular decapolar mapping catheter ( Lasso™ ) place LA one constantly perfuse long sheath use monitor PVI , 3.5 mm 7F externally irrigated-tip ablation contact force sense catheter ( SmartTouch™ ) , place within LA second constantly irrigate long sheath . A LA anatomy shell create aid Carto3 system ( Biosense Webster ) . This shell merge 3D compute tomography scan acquire prior ablation procedure depend operator 's choice . Pulmonary vein isolate two-by-two antral level create continuous circular lesion . The carina region target PVs could isolate despite complete circular lesion creation around PVs ostia . Radiofrequency ablation setting use : 30 W/48°C/17 ml per minute except posterior LA wall ( 25W/48°C/17 ml per min ) ridge ( 35W/48°C/30 ml per min ) . Thirty minute PVI , entrance exit block rechecked PV . In case PV reconnection , supplemental RF application perform order re-isolate PVs follow two-step approach . Evaluation unipolar signal modification : every radiofrequency ( RF ) delivery perform minimal 10 g force , entire RF application last 10 second unipolar atrial electrogram , record ablation catheter , always demonstrate positive-negative morphology ablation , become complete positive signal ( except posterior LA wall 5 supplemental second add ) . During individual RF application , modification unipolar atrial electrogram monitor real-time Carto™ system sweep speed 200mm/s . Reference annotation signal record bipolar signal either electrodes 1-2 3-4 non-deflectable 6F hexapolar catheter , depend whether latter place CS high RA . Unipolar signal record 3.5mm distal electrode ablation catheter filter Carto™ system [ 0.5-120 ] Hz band-pass filter display Carto™ annotation viewer . The indifferent electrode use cathode locate level inferior vena cava . Post-ablation Management Follow-up : All patient discharge home within 3 day , enrol 12-month follow-up . Post-procedure , AAD discontinue vitamin K antagonist prescribe 3 month . Subsequently , vitamin K antagonist continue , depend CHA2DS2-VASc score patient . Patients evaluate pre-discharge , 1 , 3 , 6 , 9 12 month post-procedure . Information collect include detail cardiac medication , NYHA functional class history arrhythmias adverse event . In addition , 12-lead ECG 24-hour Holter monitor systematically obtain visit . Echocardiography perform case day procedure . No antiarrhythmic medication prescribe follow ablation . If document recurrence symptomatic AF 3-month blanking period patient require antiarrhythmic drug therapy , previously ineffective tolerated class 1 class 3 ( sotalol ) drug prefer option . Atrial tachycardia/AF recurrence consider , episode last &gt; 30 ( either symptomatic asymptomatic ) subsequent 3-month blanking period .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Paroxysmal symptomatic drug resistant atrial fibrillation ( AF ) . Paroxysmal AF consider episode AF terminate spontaneously less seven day . age &lt; 18 &gt; 80 yearold leave atrial volume &gt; 200 ml presence mechanical mitral valve prosthesis impair thyroid function leave ventricular ejection fraction &lt; 40 % patient guardianship contraindication anticoagulant therapy current malignancy prior catheter surgical AF ablation persistent longstanding persistent AF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Catheter Ablation</keyword>
	<keyword>Pulmonary Vein Isolation</keyword>
	<keyword>Radiofrequency</keyword>
</DOC>